Page last updated: 2024-08-17

methionine and Lung Adenocarcinoma

methionine has been researched along with Lung Adenocarcinoma in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (50.00)24.3611
2020's2 (50.00)2.80

Authors

AuthorsStudies
Chang, QH; Chang, R; Mao, T; Wang, N; Xu, ZJ; Ye, Y; Zhang, DY; Zhang, YC1
Beverly, LJ; Clem, BF; Filho, FSL; Hallam, SJ; Johnson, FD; Lam, S; Lam, WL; Leung, JM; Lockwood, WW; Marshall, EA; Nislow, C; Noonan, AJC; Pewarchuk, ME; Shah, PP; Stewart, GL; Vega, AA; Vucic, EA; Yang, J1
Asano, H; Furukawa, M; Hagiwara, K; Hashida, S; Miyoshi, S; Shien, K; Soh, J; Tanaka, T; Toyooka, S; Tsukuda, K; Yamamoto, H1
Hackl, S; Kramer, M; Siska, P; Weber, F; Wesierska-Gádek, J; Zulehner, N1

Other Studies

4 other study(ies) available for methionine and Lung Adenocarcinoma

ArticleYear
A novel methionine metabolism-related signature predicts prognosis and immunotherapy response in lung adenocarcinoma.
    Aging, 2023, 05-02, Volume: 15, Issue:9

    Topics: Adenocarcinoma of Lung; Humans; Immunotherapy; Lung Neoplasms; Methionine; Prognosis; Racemethionine; Tumor Microenvironment

2023
Methionine-producing tumor micro(be) environment fuels growth of solid tumors.
    Cellular oncology (Dordrecht), 2023, Volume: 46, Issue:6

    Topics: Adenocarcinoma of Lung; Animals; Cell Line, Tumor; Cell Proliferation; Escherichia coli; Gene Expression Regulation, Neoplastic; Humans; Lung Neoplasms; Mammals; Methionine; Racemethionine; S-Adenosylmethionine; Tumor Microenvironment

2023
Presence of the minor EGFR T790M mutation is associated with drug-sensitive EGFR mutations in lung adenocarcinoma patients.
    Oncology reports, 2014, Volume: 32, Issue:1

    Topics: Adenocarcinoma; Adenocarcinoma of Lung; Adult; Aged; Aged, 80 and over; Cell Line, Tumor; Drug Resistance, Neoplasm; ErbB Receptors; Exons; Female; Genetic Predisposition to Disease; Humans; Lung Neoplasms; Male; Methionine; Middle Aged; Mutation; Sequence Deletion; Threonine

2014
Combining an FPTase inhibitor with cisplatin facilitates induction of apoptosis in human A549 lung cancer cells.
    Journal of experimental therapeutics & oncology, 2011, Volume: 9, Issue:1

    Topics: Adenocarcinoma; Adenocarcinoma of Lung; Alkyl and Aryl Transferases; Antineoplastic Agents; Apoptosis; Caspases; Cell Cycle; Cell Proliferation; Cisplatin; Drug Synergism; Drug Therapy, Combination; Flow Cytometry; Humans; Immunoblotting; Lung Neoplasms; Methionine; Proto-Oncogene Proteins; Proto-Oncogene Proteins p21(ras); ras Proteins; Tumor Cells, Cultured; Tumor Suppressor Protein p53

2011